StrategyStates Move Ahead With Canada Drug Importation While Awaiting Signal From Biden
The Pharmaceutical Research and Manufacturers of America, an industry trade group, filed suit in federal court in Washington, D.C., to...
Clinical CareFewer Physicians Accepting Industry Payments, But Payment Values Stay Steady
A new study highlights the importance of tracking physician conflicts of interest.
StrategyDrug Lobby Rips Trump's 'Most Favored Nation' Mandate on Medicare Drug Prices
PhRMA says the White House has "doubled down on a reckless attack on the very companies working around the clock...
FinancePharmacists Call on N.Y. to Lift Restrictions to Fight Coronavirus
The Pharmacists Society of the State of New York released a six-point plan to address the outbreak.
FinanceRevenues Jumped 32% for CVS, Operating Income up to $12B
The company made a series of leadership changes in addition to releasing its earnings report.
FinanceAllergan Shareholders Approve $63B Abbvie Acquisition
The deal, first announced in June, received near-unanimous approval from the Dublin-based pharmaceutical company's shareholders.
FinanceCalifornia's New Transparency Law Reveals Steep Rise In Wholesale Drug Prices
Generic drugs saw the largest median increase of 37.6% from 2017 through the first quarter of 2019.
FinancePhRMA: Pelosi Bill Would Mean 'Lights Out' for Drug Startups
Drug lobby, feeling heat from Capitol Hill, ramps up its rhetoric.
FinanceLarge Chain Pharmacies Have Lowest Cash Prices for Generics, Less Variation
Consumers might be better off price shopping for generic prescription drugs, according to a new study.
FinanceMedicaid Pharmacy Cost Trend Increases Despite Drop in Utilization
One of the most notable data points was the nearly flat rate for average claim cost, increasing 0.8%, compared to...
FinancePharma Cash Rolls Into Congress To Defend An Embattled Industry
The big contributions that lawmakers are getting signal that the pharmaceutical industry is building loyalty ahead of the 2020 elections.
FinanceCelgene Sells Otezla to Amgen for $13.4B, Bristol-Myers Squibb Announces
The announcement is the latest development as New York-based Bristol-Myers Squibb looks to close on its purchase of Celgene.